This website, owned by Alantra Partners S.A., uses cookies, including third-party cookies, to better understand how you use our website, offer better functionality and customization levels. For more information on how we use cookies, please see our Cookie Policy. Please, configure your cookie preferences or accept them all to continue navigating in our website.
Config Accept
Search

What we do / Investment Banking / Transactions / Alantra advised Lydall on the sale of Charter Medical

Alantra advised Lydall on the sale of Charter Medical

SECTORHealthcare; Industrials

ServiceM&A

Value $29.9 million

Jan 2015
Sell-side advisory
Value $29.9 million

Alantra advised Lydall, Inc. (NYSE:LDL) on the sale of Charter Medical Ltd. to a US subsidiary of Fenner PLC (LSE:FENR), for $29.9 million

View Healthcare View The United States

Related Transactions

View All